Final Rule on reporting and recordkeeping requirements for PFAS
The US Environmental Protection Agency (EPA) has issued a final rule on reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) through… read more
The US Environmental Protection Agency (EPA) has issued a final rule on reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) through… read more
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more
Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team… read more
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more
ToxStrategies’ scientists Amy Sheppard and Jennifer van de Ligt collaborated with a team of industry scientists from Cargill to evaluate the safety of… read more
ToxStrategies will be attending and exhibiting at the International Production & Processing Expo (IPPE) in Atlanta, GA from January 30 to February 1,… read more
The US Environmental Protection Agency (EPA) has announced that it is beginning the 12-month process to prioritize five additional chemicals for risk evaluation… read more
ToxStrategies scientists LeeAnn Racz, Alison Gauthier, Jennifer Bare, Melissa Heintz, David Feifarek, Stephanie Kennedy, and Julie Panko assessed the risk of human and… read more